For example, the pH-responsive exosome nano-bioconjugates composed of M1 macrophages-derived exosomes with antibodies of anti-CD47 and anti-SIRPα through acid-cleavable benzoic-imine bonds has been developed to target the tumor cells. The gene discussed is SIRPA; the disease is neoplasm.